openPR Logo
Press release

Investigation announced for Investors in shares of Livongo Health, Inc. (NASDAQ: LVGO) over possible Violations of Securities Laws

10-15-2019 09:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Livongo Health, Inc. (NASDAQ: LVGO) shares over potential securities laws violations by Livongo.

An investigation for investors in Livongo Health, Inc. (NASDAQ: LVGO) shares over potential securities laws violations by Livongo.

An investigation was announced concerning possible violations of securities laws by Livongo Health, Inc. in connection with certain financial statements.

Investors who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Livongo Health, Inc. (NASDAQ: LVGO) concerning whether a series of statements by Livongo Health, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Mountain View, CA based Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. On July 24, 2019, Livongo Health, Inc announced the pricing of its initial public offering (“IPO”) of approximately 12.7 million shares at $28.00 per share. Livongo Health, Inc raised $355.60 million in its IPO.

Since, the IPO shares of Livongo Health, Inc. (NASDAQ: LVGO) declined to as low as $15.12 per share on October 2, 2019.

Those who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Livongo Health, Inc. (NASDAQ: LVGO) over possible Violations of Securities Laws here

News-ID: 1849780 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Livongo

Digital Therapeutics Market Hits New High | Major Giants Omada, Livongo, CureApp …
HTF MI just released the Global Digital Therapeutics Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major Giants in Digital Therapeutics Market are: Omada, Pear Therapeutics, Akili, Kaia,
Digital Health Coaching Market Is Booming So Rapidly | Noom, Livongo, Healthify
The Global Digital Health Coaching Market Size is estimated at $13.6 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.8% to reach $40.2 Billion by 2034. The latest study released on the Global Digital Health Coaching Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Digital Health Coaching market study covers significant research data and proofs to be a handy
Telehealth Technology Market Next Big Thing | Major Giants Allscripts, Livongo H …
The latest study released on the Global Telehealth Technology Market by AMA Research evaluates market size, trend, and forecast to 2027. The Telehealth Technology market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in
Digital Pills Market is Booming Worldwide with PureTech Health, Livongo Health, …
Digital Pills Market - Global Outlook and Forecast 2022-2028 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Digital Pills Market. Some of the key players profiled in the study are Proteus Digital Health, Inc, Otsuka
Investigation announced for Investors in Livongo Health, Inc. (NASDAQ: LVGO) ove …
An investigation was announced concerning whether the takeover of Livongo Health, Inc. is unfair to NASDAQ: LVGO stockholders. Investors who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO) and currently hold any of those NASDAQ: LVGO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain directors of Livongo Health, Inc. breached their fiduciary duties
Digital Therapeutics Market Expected to Reach At US$ 8,941.1 Mn by 2025 With Maj …
Global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant